OncoImmunology
Volume 3, 2014 - Issue 2
Open access
251
Views
17
CrossRef citations to date
0
Altmetric
Author's View
Two is better than one: Complementing oncolytic virotherapy with gemcitabine to potentiate antitumor immune responses
Shashi Gujar Department of Microbiology and Immunology; Dalhousie University; Halifax, NS Canada; Strategy & Organizational Performance; IWK Health Centre; Halifax, NS Canada
, Derek Clements Department of Pathology; Dalhousie University; Halifax, NS Canada
& Patrick W.K. Lee Department of Microbiology and Immunology; Dalhousie University; Halifax, NS Canada; Department of Pathology; Dalhousie University; Halifax, NS CanadaCorrespondence[email protected]
Article: e27622
|
Received 21 Dec 2013, Accepted 22 Dec 2013, Published online: 06 Jan 2014
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.